Coronary flow and reactivity, but not arrhythmia vulnerability, are affected by cardioplegia during cardiopulmonary bypass in piglets by Petru Liuba et al.
Liuba et al. Journal of Cardiothoracic Surgery 2013, 8:157
http://www.cardiothoracicsurgery.org/content/8/1/157RESEARCH ARTICLE Open AccessCoronary flow and reactivity, but not arrhythmia
vulnerability, are affected by cardioplegia during
cardiopulmonary bypass in piglets
Petru Liuba1*, Sune Johansson2, Erkki Pesonen1, Michal Odermarsky1, Axel Kornerup-Hansen5, Anders Forslid4,
Elhadi H Aburawi6, Thomas Higgins1, Malene Birck5 and Valeria Perez-de-Sa3Abstract
Background: Surgery under cardiopulmonary bypass (CPB) is still associated with significant cardiovascular
morbidity in both pediatric and adult patients but the mechanisms are not fully understood. Abnormalities in
coronary flow and function have been suggested to play an important role. Prior studies suggest protective effects
on coronary and myocardial function by short intravenous (i.v.) infusion of cyclosporine A before CPB.
Methods: Barrier-bred piglets (10–12 kg, n=20) underwent CPB for 45 min, with or without antegrade
administration of cardioplegic solution. Prior to CPB, half of the animals in each group received an i.v. infusion of
100 mg/kg cyclosporine A. The left anterior descending coronary flow velocity responses to adenosine, serotonin,
and atrial pacing, as well as left ventricular function and postsurgical vulnerability to atrial fibrillation (Afib) were
assessed by intracoronary Doppler, epicardial echocardiography, and in vivo electrophysiological study, before and
8 hours after surgery. Plasma C-reactive protein (CRP) and fibrinogen were measured at both time-points.
Results: Cyclosporine infusion did not influence any of the studied variables (p>0.4). Coronary peak flow velocity
(cPFV) rose significantly after surgery especially in the cardioplegia group (p<0.01 vs. non-cardioplegia group and
pre-surgery). cPFV responses to adenosine, but not to serotonin, tended to decrease (p=0.06) after surgery only in
cardioplegia group (p=0.06; p=0.8 in non-cardioplegia group vs pre-surgery). Also, cPFV response to atrial pacing
was lower in the cardioplegia than in the non-cardioplegia group (p=0.02). Neither vulnerability nor duration of
induced Afib after CPB differed between groups (Chi-square p=0.4). Cyclosporine had no significant effect on
coronary indexes or arrhythmia vulnerability (p>0.4). There was no difference in systolic myocardial function
between groups at any time point.
Conclusion: In piglets, CPB with cardioplegia was associated with profound abnormalities in coronary vasomotor
tone and receptor-related flow regulation, whereas arrhythmia vulnerability appeared to be comparable with that in
non-cardioplegia group. In this study, preconditioning with cyclosporine had no detectable protective effect on
coronary circulation or arrhythmia vulnerability after CPB.
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The survival and quality of life of patients with conge-
nital heart disease (CHD) undergoing surgery with
cardiopulmonary bypass (CPB), even with very complex
cardiac malformations, has improved significantly during
the past decade. Nevertheless, surgery with CPB remains
associated with appreciable cardiovascular morbidity in
both pediatric and adult patients [1]. Recent clinical
studies have highlighted several modifiable and nonmo-
difiable risk factors which could affect the cardiac func-
tion; intraoperative variables such as duration of CPB
and aortic cross-clamping, type and temperature of
cardioplegic solution seem to significantly influence the
postoperative outcome [1,2]. Although the mechanisms
whereby these different factors, together or independ-
ently, influence cardiovascular function remain unclear,
perioperative changes in coronary flow and function
might be a common pathway [3].
A prior study suggested that coronary vasomotor func-
tion is altered by cold crystalloid cardioplegia [4], but to
a less extent by warm blood cardioplegia [5]. These
changes appear to involve both the microvascular [6]
and epicardial [7] coronary bed with significant coronary
endothelial damage and apoptosis. A study by Oka et al.
[8] suggested that addition of cyclosporine A to the
cardioplegic solution could alleviate cardiomyocyte’s
mytochondrial dysfunction and hence protect the myo-
cardium against CPB-related ischemic injury.
We have earlier demonstrated that coronary flow is
altered after surgery with CPB in children with CHD [9].
The observation of increased coronary blood flow after
surgery with CPB, particularly in the setting of impaired
coronary vasomotor function, should intuitively suggest
decreased coronary flow reserve, which has been specu-
lated to contribute to myocardial dysfunction and ar-
rhythmias postoperatively [10]. To our knowledge, the
relationship between coronary vasomotor function and
arrhythmia vulnerability in the early postoperative period
has not yet been investigated.
In the present study, we investigated whether adminis-
tration of normothermic blood cardioplegia influence
coronary and myocardial function after CPB in young
miniaturized pigs, and whether these changes could be
prevented by preoperative intravenous infusion of cyclo-
sporine A. The threshold of postoperative tachyarrhyth-
mia was also studied.
Methods
Twenty barrier-bred, specific-pathogen-free, 8-9-week
old, Göttingen minipigs (Ellegaard Göttingen Minipigs,
Dalmose, Denmark), housed in a barrier-protected ani-
mal facility under controlled conditions (temperature
between 18 and 22°C and relative humidity 30–60%)
were allowed to acclimatize for 1 week before the startof the study. All animals received proper care in compli-
ance with the Swedish Ethics Guidelines for the use of
laboratory animals.
On the study day, the animals were randomized to one
of the study groups and sedated with a mixture of
ketamin and midazolam (10 mg/kg and 1 mg/kg, respect-
ively) given intramuscularly before a 22 G cannula was
inserted into an ear vein. Under sedation with propofol
i.v. (approximately 0.5 - 2 mg/kg), the animals were orally
intubated with a cuffed endotracheal tube (size 3.5 - 4.5).
Mechanical ventilation was then started with oxygen-
enriched room air (air and pure O2 in ratio of 2.2:1; 8 mL/kg,
30 breaths/min, 5 PEEP) using a Siemens SERVO 300 res-
pirator (Siemens, Erlangen, Germany).
The animals were subsequently placed prone on an
X-ray table and monitored with pulse oximetry (% SpO2)
and a 3-lead EKG. Central temperature was monitored
by a rectal probe. Through surgical cutdown, a 5F
double-lumen central venous catheter (COOK Medical
Inc, IN, USA) was inserted into the left internal jugular
vein for drug administration and central venous pressure
monitoring, and a 20 G cannula was inserted into the
left carotid artery for blood pressure monitoring and
blood sampling. A baseline blood sample was taken and
preserved in ice for C-reactive protein, plasma lipids and
fibrinogen analysis. Intracoronary doppler velocimetry
was thereafter performed according to the protocol de-
scribed below.
Following coronary assessment, the animals received for
10 minutes an intravenous infusion of either cyclosporine
A 100 mg/kg or saline via the central venous line. Cardiac
rhythm monitoring with a portable Holter system was
performed for 5 minutes preoperatively and continued im-
mediately after surgery until the end of the postoperative
coronary assessment (8 hours after surgery).
Coronary velocimetry protocol
The coronary flow velocity study was performed before
and 6–8 hours after completion of surgery [11,12]. After
an intravenous bolus of 100 IU/kg heparin, a 4F short
sheath was inserted into the right carotid artery and a 4F
Judkins right coronary catheter was advanced into the
ostium of the left coronary artery (LCA) under fluoros-
copy guidance. A Volcano ComboWire (Pressure/Flow
Guide .014″ Wire, Volcano, CA, USA) connected to a
real-time spectrum analyzer (ComboMap System, model
6800, Volcano, CA, USA), was then inserted through the
catheter and positioned in the mid-part of the left anter-
ior descending coronary artery (LAD). Coronary aver-
aged peak velocity (APV) and pressure were displayed
continuously on the system’s monitor. Data were stored
on the hard disk for off-line analysis. After stabilization
of the baseline Doppler signal, intracoronary adenosine
(5 μg/kg), bradykinin (10−6 M), and serotonin (10−6 M)
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peak averaged velocity assessed. All drugs were given in
succession 10 min apart, and in the same order, in all
animals. Complete recovery of coronary flow velocity
and pressure (ie, steady state) was attained in each ani-
mal before the next drug was given.
Before administration, all drugs were diluted with 0.9%
saline to a volume of 3 ml. A recovery period of 10 min
was allowed between drug administration until the cor-
onary flow velocity values returned to baseline.
Postoperatively, coronary velocity response to incre-
mental increases in heart rate (20 beats/minute every 2
minutes up to 60 beats/minute over the baseline heart
rate) was assessed as well.
Echocardiography
Epicardial echocardiography was performed before the
start of CPB (after thoracotomy) and 6–8 hours after
CPB, immediately before the postoperative coronary
flow study. A Philips ultrasound system (Royal Philips
Electronics, Amsterdam, The Netherlands) equipped
with a 7-MHz probe was used. Standard 4- and 5-
chamber apical and short-axis parasternal views were
obtained in all animals. Left ventricle’s (LV) and aortic
valve dimensions, aortic outflow signal and mitral inflow
signal were assessed by Doppler as earlier described [13].
All images were stored on the system’s hard disk for
later analysis of LV area and volume, systolic function
(ejection fraction and shortening fraction), and diastolic
function (mitral E/A ratio, total and “E”/“A”VTI).
CPB
Through a median sternotomy, the pericardium was
opened, and the aorta and caval veins cannulated after
heparinization (300 U/kg). CPB, using a centrifugal
pump (Bio-Medicus, Medtronic USA inc., MN, USA)
and a pediatric membrane oxygenator (Minimax Plus,
Medtronic USA inc., MN, USA), was instituted with a
flow rate of 2.5-3 L/min/m2, and the animals were sys-
temically cooled to 32 degrees Celsius. The system was
primed with 500 mL of whole blood stabilized with cit-
rate (Veterinary Pharmacy, University of Copenhagen,
Denmark) sampled 3–6 days prior to surgery from
slaughter pigs anaesthetized with isoflurane (Baxter,
Allerød, Denmark). The hematocrit was maintained be-
tween 25% to 30%, and the mean arterial pressure
around 60 mm Hg. CPB was carried out for 45 min, ei-
ther without (n=10) or with antegrade administration for
20 minutes of blood cardioplegia (n=10). The ascending
aorta was thereafter cross-clamped, and a double-lumen
aortic root cannula inserted for antegrade delivery of
cardioplegic solution. Cardioplegia was given via a roller
pump that mixed oxygenated blood with modified St
Thomas’ cardioplegic solution in a 4:1 ratio (30 ml/kg),at a pressure of ca 60 mm Hg. The cardioplegic solution
was kept at room temperature before delivery. During
weaning from CPB, all animals were started on dopa-
mine 5 μg/kg/min, milrinone 0.5 μg/kg/min (mainten-
ance dose), and 5% albumin (50 mg/ml, CSL Behring,
Danderyd, Sweden) 25 ml/hour in order to maintain
stable hemodynamics. Epicardial electrodes were placed
in standard position (2 on the right atrium and 2 on the
right ventricle) for later cardiac pacing during coronary
velocity assessment.
Statistics
All coronary responses to vasoactive agonists and
cardiac pacing are expressed as a ratio of peak (after
drug infusion) to baseline (before drug infusion) veloci-
ties (peak-to-baseline). Significant differences between
groups in numerical variables were calculated with
ANOVA followed, when indicated, by Bonferroni post-
hoc test. To reduce the impact of scattering and skew-
ness, given the small number of animals, all numerical
variables were log-transformed. Differences were consid-
ered statistically significant at P < 0.05. Statistical ana-
lysis was carried out with SAS 9.1 (SAS Institute, Cary,
NC). Data are presented as means and SD. Mean arterial
pressure and blood gases (O2 and CO2) were maintained
within normal range in all animals postoperatively.
Results
Two animals died postoperatively, one from the noncar-
dioplegia&cyclosporine group due to ventricular fibrilla-
tion (no resuscitation attempted) and the other one from
the cardioplegia & non-cyclosporine group due to recur-
rent massive bleeding. All data from these animals were
therefore discarded.
Cyclosporine on post-CPB variables
Cyclosporine had no significant effect on coronary
indexes or arrhythmia vulnerability (p>0.4). Neither
inflammatory or lipid variables were influenced by cyclo-
sporine (p>0.5).
There were no significant differences in MAP or blood
gases between treatment groups (p>0.4). All animals
were in sinus rhythm after CPB. Holter analysis during
the postoperative period revealed short-lasting, hemody-
namycally insignificant episodes of atrial-ventricular
block II, supraventricular tachycardia and atrial fibrilla-
tion/flutter (AFib/AF) in nearly all animals. The fre-
quency and duration of AFib/AF were similar in all
groups (p>0.2).
Inflammatory and lipid data
Neither C-reactive protein (CRP) nor fibrinogen concen-
trations differed between the groups at any timepoint
(p>0.05). Among lipid variables, HDL dropped significantly
Figure 2 Peak coronary flow velocity response (expressed as
peak-to-baseline ratio) to incremental increase in heart rate via
cardiac pacing after surgery with (empty squares) and without
(solid squares) cardioplegia.
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relatively unchanged in the noncardiopegia group (p>0.1).
Cyclosporine had no influence on any of these variables
(p>0.2).
Coronary peak velocity assessment
Coronary peak flow velocity (cPFV) rose significantly after
surgery in both cardioplegia and noncardioplegia animals
(p<0.01 vs. pre-surgery for both groups), with the largest
velocity increase in the cardioplegia group (p=0.001 vs
noncardioplegia group; Figure 1). cPFV responses to adeno-
sine, but not to serotonin (p>0.2), tended to decrease after
surgery only in the cardioplegia group (p=0.06). In contrast,
cPFV response to atrial pacing was lower in cardioplegia
than in non-cardioplegia animals (p=0.02; Figure 2).
Arrhythmia threshold
Afib was induced in all animals postoperatively at a
threshold of 180–200 msec. However, neither this nor the
duration of induced Afib differed between groups (p=0.4).
Epicardial echocardiography data
LV end-diastolic diameters were significantly larger after
CPB (p=0.03), whereas postoperative EF and SF were
comparable to preoperative values (p>0.2). Similarly, CO
and mitral inflow variables (E/A, total velocity time inte-
gral (VTI), and VTI“E”/VTI“A”) remained unchanged as
compared to preoperative values (p>0.1).
Discussion
Using reproducible and sensitive in-vivo methods for
evaluation of coronary vasomotor and cardiac function
[13,14], we aimed to assess whether the use of tepidFigure 1 Baseline averaged coronary flow velocities in animals
before (empty bar), and after surgery with (light gray bar) and
without cardioplegia (dark gray bar).blood cardioplegia during CPB of miniature piglets
would affect the heart and the coronaries during the first
hours after surgery, and whether preconditioning with
cyclosporine A could alleviate the putative negative
impact of cardioplegia on these indexes. Inflammatory
and lipid indexes were also assessed. Using several vaso-
active agonists known to dilate the coronaries through
separate molecular endothelium-dependent and inde-
pendent mechanisms, we observed cardioplegia-related
abnormalities in coronary vasomotor tone and reactivity
6 to 8 hours post-CPB, though both the inflammatory
markers (C-reactive protein and fibrinogen) and the
myocardial function (assessed by epicardial standard
echocardiography) were comparable to preoperative
values. Furthermore, blood cardioplegia did not seem to
influence in any way the susceptibility to postoperative
arrhythmias, as demonstrated by the equal frequency of
spontaneous and stimulator-induced rhythm distur-
bances in the cardioplegia and non-cardioplegia groups.
No significant preconditioning effect of cyclosporine on
coronary function was demonstrated. In the present
study, the coronary flow measurements were achieved
using the Volcano Combomap® system, which has the
advantage of assessing simultaneously both pressure and
flow velocity (Figure 3/Panel A) via a 0.014″ coronary
wire (Figure 3/Panel B). Our group has a certain expert-
ise with using this device in the swine model [11,12].
Cardiopulmonary bypass (CPB) remains a central part
of surgery of congenital heart defects in both pediatric
and adult patients [1]. In spite of major technical im-
provements in the performance of CPB during the past
two decades, cardiovascular complications, particularly
during the early postoperative period, are still present.
While postoperative tachyarhythmias, often in form of
atrial fibrillation (AFib), are more common in adults,
Figure 3 Illustration of Volcano ComboMap system and Combowire. Panel A: Volcano ComboMap® screenshot showing both pressure and
flow measurements in coronary circulation; Panel B: illustration of Combowire used for intracoronary flow and pressure assessment.
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ary and systemic hypertension, appear to be less age-
related, with a greater prevalence among patients with
depressed cardiac function at the time of surgery [1,2,15].
Prior in-vitro studies have provided suggestive evidence
that some of these complications might relate to profound
coronary and systemic vascular dysfunction that occurs
during reperfusion [4-7]; others [8,16] have suggested po-
tential benefit in partially reversing these effects by sub-
stances with protecting effects of vascular endothelium
and cardiomyocites (pre- or postconditioning).
The increase in coronary flow after cardiac surgery has
been demonstrated both in animal and clinical studies
[9,17], but the replication of this phenomenon in the
present study is a key finding, since tepid blood was used
instead of cold crystalloid cardioplegia. The mechanisms
might relate to elevated circulating levels of cytokines (not
measured in this study), in particular tumor necrosis
factor-alpha (TNF- α), and complement activation [18],
which are triggered mainly through the contact between
the blood and the foreign surface of the CPB circuit. TNF-
α upregulates inducible nitric oxide (NO) synthase activity
with secondary increased release of NO, thereby contribu-
ting to the reduction in the intrinsic tone of the coronary
microcirculation [19]. Increased amounts of intravascular
NO lead to formation of peroxynitrate, which is highly
damaging for endothelial cells [20]. This effect is further
exacerbated by ischemia-reperfusion injury [21]. The in-
volvement of the coronary endothelium is also suggested
by the difference in coronary velocity response to cardiac
pacing, which is known to cause dilatation through the re-
lease of endothelial NO [22,23]. Dysfunction of coronary
smooth muscle cells might occur as well, as indicated by
the mildly impaired coronary response to adenosine.
In the present study, preconditioning with cyclosporine
A prior to CPB conferred no observable protection oneither coronary flow or function postoperatively. Al-
though, in high doses, ie, following cardiac transplant-
ation as an immunosuppressive agent, cyclosporine is
known to deter coronary endothelial function [24], when
used in lower doses for short periods of time or as
addition to the cardioplegia solution, it appears to exert
favourable effects on both the cardiomyocytes and co-
ronary vascular function [8,25]. Cyclosporine A has been
reported to ameliorate reperfusion injury in several
in vitro and in vivo animal models of unprotected and
protected ischemia [26,27]. In a neonatal piglet model of
cardioplegic arrest [8], cyclosporine A was shown to pre-
vent apoptosis-related mytocondrial dysfunction. Similar
effect of cyclosporine A on mitochondria was demon-
strated in a rabbit model of ischemia-reperfusion, and
was associated with improved post-cardioplegia myocar-
dial performance [28]. Therefore we decided to test its
eventual efficacy in protecting the coronary function in
this animal model. The lack of effect in the present study
could be explained in part by the relatively mild coronary
dysfunction, which, perhaps in conjunction with the
postoperative use of milrinone [29], another drug with
important vasoprotective action, might have concealed a
potential effect of cyclosporine. The preserved postope-
rative myocardial function, documented by echocardiog-
raphy, could support this assumption.Conclusions
In conclusion, cardioplegia with tepid blood during sur-
gery with CPB in piglets was associated with abnormalities
in coronary vasomotor tone and receptor-related flow
regulation, whereas myocardial function appeared to be
preserved. In this study, preoperative administration of
cyclosporine had no observable protective effect on coro-
nary circulation or arrhythmia vulnerability after CPB.
Liuba et al. Journal of Cardiothoracic Surgery 2013, 8:157 Page 6 of 6
http://www.cardiothoracicsurgery.org/content/8/1/157Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
PL designed the study, performed the coronary Doppler study, contributed
to the statistical analysis, and drafted the manuscript. SJ performed the
cardiac surgery. EP contributed to the coronary Doppler study. MO
participated in the analysis of the coronary and heart rhythm data. TH and
EA performed the cardiac ultrasound study. VP, AKH, AF, and MB were
responsible for sedation and anaesthesia, and the periperative care of
animals. All authors read and approved the final manuscript.
Acknowledgements
We are most indebted for the very kind support and cooperation of Dr Jens
Johansson, pediatric cardiac surgeon, Dr Eric Johansson, and perfusionists
Ann-Katrin Krokström and Thomas Hansson. We are also most grateful to
Annica Maxedius, research nurse, for invaluable technical assistance
throughout the study. The study was supported via grants from Lund
University Hospital, and the Swedish Heart-Lung Foundation.
Author details
1Division of Cardiology, Children’s Heart Center, Skåne University Hospital,
Lund, Sweden. 2Division of Cardiac Surgery, Children’s Heart Center, Skåne
University Hospital, Lund, Sweden. 3Division of Anesthesiology and Intensive
Care, Children’s Heart Center, Skåne University Hospital, Lund, Sweden.
4Department of Animal Science, Lund University, 22185 Lund, Sweden.
5Department of Veterinary Disease Biology, Faculty of Life Sciences,
University of Copenhagen, Copenhagen, Denmark. 6Department of
Paediatrics, College of Medicine and Health Sciences, UAE University, Al Ain,
UAE.
Received: 8 January 2013 Accepted: 4 June 2013
Published: 19 June 2013
References
1. Abarbanell GL, Goldberg CS, Devaney EJ, Ohye RG, Bove EL, Charpie JR: Early
surgical morbidity and mortality in adults with congenital heart disease: the
University of Michigan experience. Congenit Heart Dis 2008, 3:82–89.
2. Yves AG, Louagie MD, Emmanuel Gonzalez MD, Jacques Jamart MDC,
Brigitte Malhomme MS, Serge Broka MD, Michel Buche MD, Philippe M,
Eucher MD, Jean-Claude Schoevaerdts MD: Assessment of Continuous
Cold Blood Cardioplegia in Coronary Artery Bypass Grafting. Ann Thorac
Surg 1997, 63:689–696.
3. Sellke FW, Friedman M, Dai HB, Shafique T, Schoen FJ, Weintraub RM, Johnson
RG: Mechanism causing coronary microvascular dysfunction following
crystalloid cardioplegia and reperfusion. Cardiovasc Res 1993, 27:1925–1932.
4. Li S, Lin J, Lenehan E, Liu J, Long C, Liu J, Geng YJ: Myocardial protection
of warm cardioplegic induction on the isolated perfused rat heart
model. J Extra Corpor Technol 2004, 36:58–65.
5. Chang CH, Lin PJ, Chu Y, Lee YS: Impaired endothelium-dependent
relaxation after cardiac global ischemia and reperfusion: role of warm
blood cardioplegia. J Am Coll Cardiol 1997, 29:681–687.
6. Long C, Hu X, Zhang J, Xiu R, Guan Y: Changes of microvascular
vasomotion and oxygen metabolism during cooling and rewarming
period of cardiopulmonary bypass. J Extra Corpor Technol 2003, 35:13–16.
7. Yeh CH, Wang YC, Wu YC, Chu JJ, Lin PJ: Continuous tepid blood
cardioplegia can preserve coronary endothelium and ameliorate the
occurrence of cardiomyocyte apoptosis. Chest 2003, 123:1647–1654.
8. Oka N, Wang L, Mi W, Zhu W, Honjo O, Caldarone CA: Cyclosporine A
prevents apoptosis-related mitochondrial dysfunction after neonatal
cardioplegic arrest. J Thorac Cardiovasc Surg 2008, 135:123–130.
9. Aburawi EH, Berg A, Liuba P, Pesonen E: Effects of cardiopulmonary bypass
surgery on coronary flow in children assessed with transthoracic Doppler
echocardiography. Am J Physiol Heart Circ Physiol 2007, 293:1138–1143.
10. Hoffman JIE: Maximal coronary flow and the concept of coronary
vascular reserve. Circulation 1984, 70:153–159.
11. Liuba P, Pesonen E, Forslid A, Paakkari I, Kornerup-Hansen A, Kovanen P,
Pentikäinen M, Persson K, Østergård G: Protective effects of simvastatin on
coronary artery function in swine with acute infection. Atherosclerosis
2006, 186:331–336.12. Birck MM, Pesonen E, Odermarsky M, Hansen AK, Persson K, Frikke-Schmidt
H, Heegaard PM, Liuba P: Infection-induced coronary dysfunction and
systemic inflammation in piglets are dampened in hypercholesterolemic
milieu. Am J Physiol Heart Circ Physiol 2011, 300:H1595–H1601.
13. Reeves ST, Glas KE, Eltzschig H, Mathew JP, Rubenson DS, Hartman GS,
Shernan SK: Council for Intraoperative Echocardiography of the American
Society of Echocardiography; Society of Cardiovascular
Anesthesiologists. Guidelines for performing a comprehensive epicardial
echocardiography examination: recommendations of the American
Society of Echocardiography and the Society of Cardiovascular
Anesthesiologists. Anesth Analg 2007, 105:22–28.
14. Denardo SJ, Talbot L, Hargrave VK, Selfridge AR, Ports TA, Yock PG: Accuracy of
Doppler catheter measurements: effect of inhomogeneous beam power
distribution on mean and peak velocity. J Am Coll Cardiol 1997, 29:283–292.
15. Denault A, Deschamps A, Tardif JC, Lambert J, Perrault L: Pulmonary
hypertension in cardiac surgery. Curr Cardiol Rev 2010, 6:1–14.
16. Okorie M, Bhavsar D, Ridout D, Charakida M, Deanfield J, Loukogeorgakis S,
MacAllister R: Postconditioning protects against human endothelial
ischaemia–reperfusion injury via subtype-specific KATP channel activation
and is mimicked by inhibition of the mitochondrial permeability
transition pore. Eur Heart J 2011, 32:1266–1274.
17. Oskarsson G, Pesonen E, Gudmundsson S, Ingimarsson J, Sandström S,
Werner O: Coronary flow reserve in the newborn lamb: an intracoronary
Doppler guide wire study. Pediatr Res 2004, 55:205–210.
18. Sellke FW, Boyle EM Jr, Verrier ED: Endothelial cell injury in cardiovascular
surgery: the pathophysiology of vasomotor dysfunction. Ann Thorac Surg
1996, 62:1222–1228.
19. Ku DD: Coronary vascular reactivity after acute myocardial ischemia.
Science 1982, 218:576–578.
20. Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate
endothelium-derived relaxing factor. Am J Physiol Heart Circ Physiol 1986,
250:H822–H827.
21. Khan TA, Bianchi C, Ruel M, Voisine P, Li J, Liddicoat JR, Sellke FW: Mitogen-
activated protein kinase inhibitor and cardioplegia-cardiopulmonary
bypass reduce coronary myogenic tone. Circulation 2003, 108:348–353.
22. Tayama S, Okumura K, Matsunaga T, Tsunoda R, Tabuchi T, Iwasa A, Yasue
H: Influence of chronic nitric oxide inhibition of coronary blood flow
regulation: a study of the role of endogenous adenosine in
anesthetized, open-chested dogs. Jpn Circ J 1998, 62:371–378.
23. Nishikawa Y, Ogawa S: Importance of nitric oxide in the coronary artery
at rest and during pacing in humans. J Am Coll Cardiol 1997, 29:85–92.
24. Petrakopoulou P, Anthopoulou L, Muscholl M, Klauss V, von Scheidt W,
Uberfuhr P, Meiser BM, Reichart B, Weis M: Coronary endothelial
vasomotor function and vascular remodeling in heart transplant
recipients randomized for tacrolimus or cyclosporine
immunosuppression. J Am Coll Cardiol 2006, 47:1622–1629.
25. Duan X, Ji B, Yu K, Liu J, Hei F, Long C: Pharmacological postconditioning
protects isolated rat hearts against ischemia-reperfusion injury: the role
of mitochondrial permeability transition pore. ASAIO J 2011, 57:197–202.
26. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert
D, et al: Specific inhibition of the mitochondrial permeability transition
prevents lethal reperfusion injury. J Mol Cell Cardiol 2005, 38:367–374.
27. Nathan M, Friehs I, Choi YH, Cowan DB, Cao-Danh H, McGowan FX, et al:
Cyclosporin A but not FK-506 protects against dopamine-induced
apoptosis in the stunned heart. Ann Thorac Surg 2005, 79:1620–1626.
28. Oka N, Wang L, Mi W, Caldarone CA: Inhibition of mitochondrial
remodeling by cyclosporine A preserves myocardial performance in a
neonatal rabbit model of cardioplegic arrest. J Thorac Cardiovasc Surg
2008, 135:585–593.
29. Sidi A, Muehlschlegel JD, Kirby DS, Lobato EB: Administration of milrinone
before ischemia, in the presence of beta-blockade, to treat metabolic
impairment and myocardial stunning in pigs. Acta Anaesthesiol Scand
2008, 52:397–405.
doi:10.1186/1749-8090-8-157
Cite this article as: Liuba et al.: Coronary flow and reactivity, but not
arrhythmia vulnerability, are affected by cardioplegia during
cardiopulmonary bypass in piglets. Journal of Cardiothoracic Surgery 2013
8:157.
